OnDemand WTP Pricing Research

India Just Slashed Prices For Nearly 400 Cancer Drugs | Care2 Causes

India has introduced strong caps on cancer drug prices, in many cases slashing the drugs’ cost by as much as 87 percent.

On March 8, India’s National Pharmaceutical Pricing Authority (NPPA) released a list of 390 medicines used in cancer treatment which the government is now bringing under a trade cap margin of 30 percent. This creates an equivalent price reduction of up to 87 percent for patients and brings 42 new unscheduled drugs under the government’s regulatory framework.

It’s important to note that many of the drugs do not hit the upper price reduction, with many falling in the 50 to 75 percent range. About a quarter see price reductions under 25 percent. Still, India’s government predicts that these price reductions will add up to meaningful savings for some 2.2 million patients and save the country an equivalent of $115 million per year. So far, about 1,000 drugs (not just cancer drugs) have had their prices capped in this way.

Read complete article here:

India Just Slashed Prices For Nearly 400 Cancer Drugs | Care2 Causes.